New York City Health and Hospitals Corporation   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: New York City NY United States (1969)

Organization Overview

First Clinical Trial
2008
NCT01570309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Abigail Nixon | Lincoln Medical Center | New York City Health and Hospitals Corporation | Seth I. Sokol, M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Anemia, Sickle Cell (Phase 3)

Asthma (Phase 4)

Emergencies (Phase 4)

Migraine Disorders (Phase 3)

Multiple Trauma (Phase 2)

Musculoskeletal Diseases (Phase 2)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 15